Trogarzo® Receives Positive Recommendation from Scientific Advisory Group of CHMP in Europe

Apr 11, 2019
PDF Version
Supporting Materials:
Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that the Scientific Advisory Group HIV/Viral Diseases (SAG), convened by the Committee for Medicinal Products for Human use (CHMP) in Europe, has given a positive recommendation to Trogarzo® (ibalizumab).